Tianjin Eleli Technology Development
Retatrutide
Finnrick tested 16 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Tianjin Eleli Technology Development between 26 Jan 2026 and 9 Aug 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Tianjin Eleli Technology Development
Retatrutide
Tested 16 Samples
Last test 9 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Tianjin Eleli Technology Development
Samples are tested in commercial labs
Tests Count
16
Scores
AVGMINMAX
Last
9 Aug 2026
First
26 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 9 Aug 2026 | View | 20mg | 20.8mg | +4.0% | 99.80% | n/a | 16.B03.26 | White label / Silver crimp / Violet cap | Lab G | Public | |
| 13 Jul 2026 | View | 20mg | 20.7mg | +3.5% | 99.80% | n/a | 03/31/26 | No label / Silver crimp / Violet cap | Lab E | Public | |
| 26 Jun 2026 | View | 30mg | ⚠️ Sample does not contain Retatrutide | n/a | (no batch ID) | No label / Silver crimp / White cap | Lab G | Public | |||
| 26 Jun 2026 | View | 20mg | 19.1mg | -4.5% | 99.60% | n/a | May 12,2026 | No label / Silver crimp / Clear Blue cap | Lab G | Public | |
| 24 Jun 2026 | View | 10mg | 9.27mg | -7.3% | 99.90% | n/a | RT-260421-01 | Silver label / Silver crimp / Green cap | Lab E | Public | |
| 15 Jun 2026 | View | 40mg | ⚠️ Sample does not contain Retatrutide | n/a | 238 1089-83-2 | No label / Silver crimp / Green cap | Lab E | Public | |||
| 15 Jun 2026 | View | 10mg | 9.36mg | -6.4% | 99.90% | below LOQ | (no batch ID) | No label / Silver crimp / Black cap | Lab E | Public | |
| 6 Jun 2026 | View | 20mg | 22mg | +10.0% | 99.80% | n/a | 0325 | No label / Silver crimp / Black cap | Lab G | Public | |
| 8 May 2026 | View | 30mg | 28.7mg | -4.3% | 99.90% | n/a | 843096 | Silver Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | View | 30mg | 28.3mg | -5.7% | 99.90% | n/a | (no batch ID) | Silver Label / Silver Crimp / White Cap | Lab E | Public | |
| 25 Mar 2026 | View | 20mg | 20.6mg | +3.0% | 99.90% | n/a | (no batch ID) | No Label / Gold Crimp / Black Cap | Lab G | Public | |
| 3 Mar 2026 | View | 10mg | 10.2mg | +2.0% | 99.67% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 3 Mar 2026 | View | 30mg | ⚠️ Sample does not contain Retatrutide | n/a | 12/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||
| 10 Feb 2026 | View | 20mg | 21.9mg | +9.5% | 99.80% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 4 Feb 2026 | View | 10mg | 9mg | -10.0% | 98.60% | n/a | 10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 26 Jan 2026 | View | 15mg | 15.2mg | +1.3% | 99.80% | n/a | (no batch ID) | White Label / Silver Crimp / Orange Cap | Lab E | Public | |